Laboratory testing includes elevated C-reactive protein (CRP), anaemia, hypoalbuminaemia, and faecal biomarkers such as faecal calprotectin (fCP), the latter being frequently used to distinguish irritable bowel syndrome (IBS) from IBD [5] as well as monitoring treatment response and disease activity [6,7,8]. Here, CRP is linked to irritable bowel syndrome.